View Older Stories
-
Sanofi (SAN:FP) (SNY) PT Raised to EUR130 at Citi, sees 'a highly attractive risk-reward'
-
Sanofi jumps as Q1 key profit measure tops estimates; Citi reiterates Buy
-
Sanofi (SNY) shares slide following Q4 revenue miss
-
3 Rumors Pushing Around Stocks Today
-
Sanofi announces closing of Regeneron stock sale
-
Regeneron (REGN) Prices 11.8M Share Registered Direct Offering by Sanofi (SNY) at $515/Sh
-
Drugmaker Sanofi to raise over $11 billion via sale of Regeneron shares
-
Sanofi announces pricing of Regeneron stock offering
-
Citi Reiterates Buy Rating on Novartis (NVS)
-
Citi Reiterates Buy Rating on Sanofi (SNY)
-
Sanofi (SNY) Roadshow Feedback 'Refreshingly Candid' - Citi
-
UPDATE: Citi Downgrades Eli Lilly (LLY) to Neutral
-
Citi Opens Catalyst Watch on Sanofi (SNY)
-
Citi Upgrades Sanofi-Aventis (SNY) to Buy
-
Sanofi : Sanofi successfully prices USD 2 billion bond issue
-
Sanofi : Sanofi successfully prices USD 2 billion bond issue
-
Sanofi : Sanofi successfully prices USD 2 billion bond issue
-
Sanofi successfully prices EUR 8 billion of bond issues
-
Sanofi successfully prices EUR 8 billion of bond issues
-
Sanofi successfully prices EUR 8 billion of bond issues
-
Sanofi (SNY) To File Sota NDA End Of January 2018 According to Investor Event Slides - Citi
-
Tesaro (TSRO) PT Raised to $232 at Citi Amid Takeover Speculation
-
TESARO (TSRO) Considering Sale Following Takeover Approaches - Reuters
-
Citigroup Comes Out Swinging In Favor Of Tesaro (TSRO), Says Co Could Sell For $208-$238 Per Share
-
Pre-Open Stock Movers 01/06: (ETRM) (OGXI) (STML) Higher; (RT) (GIII) (REGN) Lower (more...)
-
Medivation (MDVN) Cancelled Bus Tour Has Rumor Mill Buzzing
-
Notable Analyst Rating Changes 5/3: (MEP) (RSG) (AXTI) Upgraded; (CYH) (UTX) (SRPT) Downgraded
-
Pre-Open Stock Movers 04/13: (RPRX) (ACUR) (MDVN) Higher; (CLVS) (VRX) (S) Lower (more...)
-
Sanofi successfully prices EUR 1.8 billion bond issue
-
Notable Mergers and Acquisitions 7/27: (TEVA)/(AGN) (WAB) (BECN) (SNY) (XUE)
-
Pre-Open Stock Movers 06/10: (HCC) (CTIC) (HIMX) Higher; (BDBD) (ESPR) (FRAN) Lower (more...)
-
Citi Upgrades Sanofi-Aventis (SNY) to Neutral
-
Notable Analyst Rating Changes 2/19: (COH) (VLO) (MWW) Upgraded; (I) (PCYC) (HUN) Downgraded
-
Pre-Open Stock Movers 1/5: (CNAT) (STXS) (URZ) (CEMP) Higher; (BCLI) (OAS) (SNY) Lower (more...)
-
Top 10 News for 10/27 - 10/31: Fed Ends Easing; Q3 was Tough on Social Media Giants; Apple CEO Cook Gets Personal
-
BioMarin to Present at Upcoming Investor Conferences
-
Pre-Open Stock Movers 6/20: (SHPG) (KMX) (ACHN) Higher; (MACK) (SWHC) (ORCL) Lower (more...)
-
Pre-Open Movers 4/21: (SRPT) (CBEY) (ASTM) Higher; (ATHN) (WLT) (PEIX) Lower (more...)
-
Citi Downgrades Sanofi (SNY) to Neutral
-
Pre-Open Stock Movers 9/9: (MOLX) (UNIS) (ISIS) Higher; (BIOD) (HSOL) (SCTY) Lower (more...)
-
Streetinsider.com's Hot Lunchtime Reads 01/18: (NCLH) (AAPL) (COF) (C) (CVX)
-
Mylan (MYL) is No Generic When it Comes to Growth Potential - Barron's
-
Sanofi (SNY) Prices $1B Notes Offering
-
Notable Analyst Rating Changes 09/09: (DB) (SUN) (TWX) Upgraded; (RIMM) (REGN) (SNY) Downgraded
-
Notable Analyst Rating Changes 05/04: (FSLR) (SNY) (FE) Upgraded; (MEE) (NSC) (MYL) Downgraded
-
Top 10 News Items 2/14-2/18: NYSE Euronext/Deutsche Boerse Announces Definitive Agreement, Sanofi, Genzyme Finally Approve Deal, Stocks Continue Higher, Up 28% Since Sept.
-
Raised Bid for Genzyme (GENZ) Could Be Coming as Sanofi (SNY) Scrounging for More Financing
-
Wall Street Hubbub 8/31: Saks In the Crosshairs, JPMorgan To Close Prop-Trading, Dean Foods Takeover Chatter, Dell Up To Bat on 3PAR
-
Citigroup Sees Sanofi (SNY) Paying $74-$77 for Genzyme (GENZ)
-
Citigroup Downgrades Genzyme (GENZ) to Hold

